Cell-based therapies for Parkinson disease—past insights and future potential.
about
The Application of Human iPSCs in Neurological Diseases: From Bench to BedsideMerging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseIntrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's DiseaseRecent advances in regenerative medicine to treat enteric neuropathies: use of human cellsWhole-brain 3D mapping of human neural transplant innervation.Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson's Disease.Influence of donor age on induced pluripotent stem cells.Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's DiseaseCyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's diseaseMolecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells.Induced dopaminergic neurons: A new promise for Parkinson's disease.Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Adult Neurogenesis 50 Years Later: Limits and Opportunities in Mammals.Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions.A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.Nicotinamide alone accelerates the conversion of mouse embryonic stem cells into mature neuronal populations.New and emerging medical therapies in Parkinson's disease.Intracerebral Cell Implantation: Preparation and Characterization of Cell Suspensions.Advances in surgery for movement disorders.Brain repair and reprogramming: the route to clinical translation.Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum.Non-human primate models of PD to test novel therapies.Cognitive Deficits after Cerebral Ischemia and Underlying Dysfunctional Plasticity: Potential Targets for Recovery of Cognition.Neural grafting for Parkinson's disease: challenges and prospects.Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.Historical perspective of cell transplantation in Parkinson's disease.Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.Anodal Transcranial Direct Current Stimulation Enhances Survival and Integration of Dopaminergic Cell Transplants in a Rat Parkinson Model.Priming of the Cells: Hypoxic Preconditioning for Stem Cell TherapyIAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.Andrographolide Promotes Neural Differentiation of Rat Adipose Tissue-Derived Stromal Cells through Wnt/β-Catenin Signaling Pathway.Cell therapies for Parkinson's disease: how far have we come?Neuroimmunomodulatory properties of DPSCs in an in vitro model of Parkinson's disease.Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation.Engineering new neurons: in vivo reprogramming in mammalian brain and spinal cord.Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.Towards stem cell based therapies for Parkinson's disease.Induction of axon growth in the adult brain: A new approach to restoration in Parkinson's disease.
P2860
Q26765876-71267F24-DFE2-4749-8A54-3BA9BA81E5C8Q26773485-85365343-055C-427B-8B5D-000DEC3EE9EEQ27329815-2095BCA1-8C97-43B2-BAE3-4F0D726A4BA2Q28077801-FCC9F093-7834-41C9-A894-1A78BCCB129DQ30835807-41F2C554-9F32-40BF-AD8C-81C17AA354E2Q33701172-A529A222-BAFB-4D71-99BA-15660DA04159Q33893730-50E55B3D-8D46-420E-B554-DFEDD5587EC1Q35966394-FE84BEDD-B9C3-4AC6-9CA8-12F786B7547EQ36250893-C9BC1CF6-68F4-4CCD-B255-DA98BFE751CDQ36370618-A6955476-9292-41DC-AAF9-B24E45159275Q37320970-0DF3D6FA-6722-48A8-A6CF-9876321F0689Q37600465-56B4D5EF-C471-4DD8-B055-1518B5A377D1Q37643268-2C750BC0-AC9F-4749-BEAF-BB880B44FDD3Q38552670-E3E6AA61-73FA-492B-BF43-A56FF87527B2Q38610367-FD392BFE-D614-4197-96AD-4EE7FDC93623Q38693456-CDAC2748-CF4A-4EDE-A54D-9ADA855EB2F2Q38694699-22EEDDDA-7B03-4F09-8A7B-08EAA2DB9370Q38718194-ED2FD4EB-6072-449B-952F-AA7F6D37FB7FQ38807492-D4D90830-B734-4B1D-834A-7B88EB5A6A8BQ38820199-E7C5E5B3-B81F-4EA7-9926-7BEAFA637FF1Q38829948-0DEB1127-3AE1-4DBB-8DBA-7F95D20529D7Q38999345-3FB4911B-0F8F-4DDF-9A0C-37315EFCC9EFQ39063051-80F31D81-E8B6-4EA3-8C64-6BFDE38F5D84Q39229450-5EB9377C-50BC-4362-B09A-8D3045DFACB9Q39269903-E9C8301F-9A8D-420C-854C-3431A4F8DB3BQ39282063-22C740C9-CF49-4961-8ED9-F6DD9D2BC7FEQ39332126-87B452D2-AD73-4E7F-8464-8CB9FEA6CCCEQ39429728-28EFB06C-849D-4516-AD5B-F7A81E902307Q41018807-F7AD8700-2DEC-42C5-8718-CFD7420651AEQ41664936-86C7AF1C-8D74-46C5-ABF6-9405CE02CEFFQ42267329-AED2BFB0-E1CA-4C78-AF70-5FBA531ACB22Q42376393-5FD977E2-F8E4-4BDA-8A11-ED3891AE01ECQ42709114-6BC14AC9-1E32-46C0-9B16-46A58B4066A2Q45758496-00AB5C46-5503-4647-8530-CB562F877A76Q46339332-E134FA54-6F7A-4AFA-B78E-E2D253A868E3Q47137695-29352A9B-FE26-4C2C-A0B4-7519FC03C59AQ47318536-E89CCDE8-BCE9-41A2-87EF-4D693C66457FQ47348189-ED050EAC-B144-4CAA-B990-9B8D59BA4177Q47877645-A8402F07-364D-408D-BD28-30D65AB5F3FCQ47932931-F8BDD27B-6E86-44E3-9B13-E04387B919F4
P2860
Cell-based therapies for Parkinson disease—past insights and future potential.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cell-based therapies for Parkinson disease—past insights and future potential.
@ast
Cell-based therapies for Parkinson disease—past insights and future potential.
@en
type
label
Cell-based therapies for Parkinson disease—past insights and future potential.
@ast
Cell-based therapies for Parkinson disease—past insights and future potential.
@en
prefLabel
Cell-based therapies for Parkinson disease—past insights and future potential.
@ast
Cell-based therapies for Parkinson disease—past insights and future potential.
@en
P2860
P1476
Cell-based therapies for Parkinson disease—past insights and future potential.
@en
P2093
Janelle Drouin-Ouellet
P2860
P2888
P304
P356
10.1038/NRNEUROL.2015.123
P407
P577
2015-08-04T00:00:00Z